Advertisement

Cardiology pp 83-90 | Cite as

Cardiomyopathies: Pathology and Infectious Immune Mechanisms

  • E. G. J. Olsen

Abstract

Much confusion of defining and classifying cardiomyopathies has existed in the past. As a result of the work by the Task Force set up by the World Health Organization and the International Society and Federation of Cardiology1, this has been clarified. Cardiomyopathies are now defined as “heart muscle diseases of unknown cause” and classified into three major types: dilated, hypertrophic and restrictive. For each type characteristic morphologic features exist.

Keywords

Dilate Cardiomyopathy Hypertrophic Cardiomyopathy Rheumatic Heart Disease Restrictive Cardiomyopathy Hypertrophic Obstructive Cardiomyopathy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Report of the WHO/ISFC Task Force on the Definition and Classif ication of Cardiomyopathies, Brit. Heart J., 44 No. 6:672 (1980).Google Scholar
  2. 2.
    E. G. J. Olsen, Cardiomyopathies, Cardiovasc. Clin., 4 No. 2: 239 (1972).PubMedGoogle Scholar
  3. 3.
    E. G. J. Olsen, Pathological recognition of cardiomyopathy, Postgrad. Med. J., 51:277 (1975).PubMedCrossRefGoogle Scholar
  4. 4.
    E. G. J. Olsen, Postmortem findings and histologic, histochemical, and electron microscopic findings of myocardial biopsies, in: “Cardiomyopathy and myocardial biopsy”, M. Kaltenbach, F. Loogen and E. G. J. Olsen, eds., Springer Verlag, Berlin (1978).Google Scholar
  5. 5.
    E. G. J. Olsen, “The Pathology of the Heart”, 2nd edition, p.41 Macmillan Press, Basingstoke and London (1980).Google Scholar
  6. 6.
    H. Kuhn, G. Breithardt, H. J. Knieriem, F. Loogen, A. Both, W. A. K. Schmidt, R. Stroobandt and U. Gleichmann, Die Bedeutung der endomyokardialen Katheterbiopsie für die Diagnostik und die Beurteilung der Prognose der kongestiven Kardiomyopathie, Dtsch. Med. Wochenschr., 100:717 (1975).PubMedCrossRefGoogle Scholar
  7. 7.
    E. G. J. Olsen, Edomyocardial biopsy, Brit. Heart J., 40:95 (1978).PubMedCrossRefGoogle Scholar
  8. 8.
    E. G. J. Olsen, The pathology of idiopathic hypertrophic subaortic stenosis (hypertrophic cardiomyopathy). A critical review, Am. Heart J., 100 No. 4:553 (1980).PubMedCrossRefGoogle Scholar
  9. 9.
    W. L. Henry, C. E. Clark and S. E. Epstein, Asymmetric septal hypertrophy (ASH): Echocardiographic identification of the pathognomonic anatomic abnormality of IHSS, Circulation, 47:225 (1973).PubMedCrossRefGoogle Scholar
  10. 10.
    B. J. Maron, J. E. Edwards, V. J. Ferrans, C. E. Clark, E. A. Lebowitz, W. L. Henry and S. E. Epstein, Congenital heart malformations associated with disproportionate ventricular septal thickening, Circulation, 52:926 (1975).PubMedCrossRefGoogle Scholar
  11. 11.
    J. H. Menges, R. D. Brandenburg and A. L. Brown Jr., The clinical, hemodynamic and pathologic diagnosis of muscular subvalvular aortic stenosis, Circulation, 24:1126 (1961).PubMedCrossRefGoogle Scholar
  12. 12.
    E. G. J. Olsen,”Pathology of hypertrophic obstructive cardiomyopathy. Recent advances in studies of cardiac structural metabolism, Vol. 2 — Cardiomyopathies”, E. Bajusz and G. Rona, eds., University Park Press, Baltimore, London, Tokyo (1973).Google Scholar
  13. 13.
    M. J. Davies, A. Pomerance and R. D. Teare, Pathological features of hypertrophic obstructive cardiomyopathy, J. Clin. Pathol., 27:529 (1974).PubMedCrossRefGoogle Scholar
  14. 14.
    S. Van Noorden, E. G. J. Olsen and A. G. E. Pearse, Hypertrophic obstructive cardiomyopathy. A histological, histochemical and ultrastructural study of biopsy material, Cardiovasc. Res., V:118 (1971).CrossRefGoogle Scholar
  15. 15.
    B. J. Maron and W. C. Roberts, Quantitative analysis of cardiac muscle cell disorganization in the ventricular septum of patients with hypertrophic cardiomyopathy, Circulation, 59:689 (1979).PubMedCrossRefGoogle Scholar
  16. 16.
    V. J. Ferrans, A. G. Morrow and W. C. Roberts, Myocardial ultrastructure in idiopathic hypertrophic subaortic stenosis. A study of operatively excised left ventricular outflow tract muscle in 14 patients, Circulation, 45:769 (1972).PubMedCrossRefGoogle Scholar
  17. 17.
    J. F. Goodwin, Congestive and hypertrophic cardiomyopathies. A decade of study, Lancet, i:731 (1970).CrossRefGoogle Scholar
  18. 18.
    E. G. J. Olsen,“The Pathology of the Heart”,2nd edition, p. 323, Macmillan Press, Basingstoke and London (1980).Google Scholar
  19. 19.
    W. D. Edwards, R. Zakheim and L. Mattioli, Asymmetric septal hypertrophy in childhood. Unreliability of histologic criteria for differentiation of obstructive and nonobstructive forms, Human Pathol., 8:277 (1977).CrossRefGoogle Scholar
  20. 20.
    J. N. P. Davies, Endocardial fibrosis in Africans, E. Afr. Med. J., 25:10 (1948).Google Scholar
  21. 21.
    W. Löffler, Endocarditis parietalis fibroplastica mit Bluteosinophilie ein eigenartiges Krankheitsbild, Schweiz Med. Wochenschr., 17:817 (1936).Google Scholar
  22. 22.
    I. F. Brockington and E. G. J. Olsen, Löffler’s endocarditis and Davies’ endomyocardial fibrosis, Am. Heart J., 85:308 (1973).CrossRefGoogle Scholar
  23. 23.
    A. G. Shaper, M. S. R. Hutt and R. M. Coles, Necropsy studies of endomyocardial fibrosis and rheumatic heart disease in Uganda, Brit. Heart J., 30:391 (1968).PubMedCrossRefGoogle Scholar
  24. 24.
    E. G. J. Olsen,“The Pathology of the Heart”, 2nd edition, p. 329, Macmillan Press, Basingstoke and London (1980).Google Scholar
  25. 25.
    E. G. J. Olsen, “The Pathology of the Heart”, 2nd edition, p. 317, Macmillan Press, Basingstoke and London (1980).Google Scholar
  26. 26.
    A. M. Denman, Immunological mechanisms and cardiovascular disease, in: “Immunology of Cardiovascular Disease”, M. H. Lessof, ed., Marcel Dekker Inc., New York and Basel, (1981).Google Scholar
  27. 27.
    P. G. H. Gell, R. R. A. Coombs and P. Lachmann, eds., “Clinical Aspects of Immunology”,3rd ed., Blackwell Sci. Pub., Oxford England (1974).Google Scholar
  28. 28.
    C. Kawai and T. Takatsu, Clinical and experimental studies on cardiomyopathy, N. Engl. J. Med., 293:592 (1975).PubMedCrossRefGoogle Scholar
  29. 29.
    G. Cambridge, C. G. C. MacArthur, A. P. Waterson, J. F. Goodwin and C. M. Oakley, Antibodies to Coxsackie B viruses in congestive cardiomyopathy, Brit. Heart J., 41:692 (1979).PubMedCrossRefGoogle Scholar
  30. 30.
    S. K. Das, L. D. Stein, R. T. Reynolds, P. Thebert and J. T. Cassidy, Immunologic studies in cardiomyopathy and pathophysiologic implications, in: “Congestive Cardiomyopathy, Kiruna Sweden 1980”, J. F. Goodwin, A. Hjalmarson and E. G. J. Olsen, eds., AB Hässle, Mölndal Sweden (1981).Google Scholar
  31. 31.
    H. D. Bolte and P. Schultheiss, Immunological results in myocardial diseases, Postgrad. Med. J., 54:500 (1978).PubMedCrossRefGoogle Scholar
  32. 32.
    S. K. Das, R. E. Petty, W. L. Mengs and D. G. Tubergen, Cell mediated immunity in cardiomyopathy, Circulation, 53/54 suppl. 2:II–22 (1976).Google Scholar
  33. 33.
    R. E. Fowles, C. P. Bieber and E. B. Stinson, Defective in vitro suppressor cell function in idiopathic congestive cardiomyopathy, Circulation, 59:483 (1979).PubMedCrossRefGoogle Scholar
  34. 34.
    J. R. Darsee, S. B. Heymsfield and D. O. Nutter, Hypertrophic cardiomyopathy and HLA linkage, N. Engl. J. Med., 300:877 (1979).PubMedCrossRefGoogle Scholar
  35. 35.
    F. A. Ive and I. F. Brockington, Endomyocardial fibrosis and filariasis (letter), Lancet, 1:212 (1966).CrossRefGoogle Scholar
  36. 36.
    A. G. Shaper, Endomyocardial fibrosis and rheumatic heart disease, Lancet, 1:639 (1966).PubMedCrossRefGoogle Scholar
  37. 37.
    E. H. O. Parry and D. G. Abrahams, The natural history of endomyocardial fibrosis, Q. J. Med., 34:383 (1965).PubMedGoogle Scholar
  38. 38.
    A. G. Shaper, The geographical distribution of endomyocardial fibrosis, Pathol. Mecrobiol., 35:26 (1970).Google Scholar
  39. 39.
    E. G. J. Olsen and C. J. S. Spry, The pathogenesis of Löffler’s endomyocardial disease, and its relationship to endomyocardial fibrosis, in: “Progress in Cardiology, 8”, P. N. Yu and J. F. Goodwin, eds., Lea & Febiger, Philadelphia (1979).Google Scholar
  40. 40.
    D. J. McLaren, F. J. Ramalho-Pinto and S. R. Smithers, Ultrastructural evidence for complement and antibody-dependent damage to schistosomula of Schistosoma mansoni by rat eosinophils in vitro, Parasitology, 77:313 (1978).PubMedCrossRefGoogle Scholar
  41. 41.
    E. G. J. Olsen, Diagnostic value of the endomyocardial bioptome (Annotation), Am. Heart J., 91:398 (1976).PubMedCrossRefGoogle Scholar
  42. 42.
    K. Daly, P. J. Richardson, E. G. J. Olsen, J. Pattison, G. Jackson and D. E. Jewitt, Immunosuppressive therapy in acute inflammatory myocarditis, Circulation, 64 suppl. 4:IV–27 (1981).Google Scholar

Copyright information

© Springer Science+Business Media New York 1984

Authors and Affiliations

  • E. G. J. Olsen
    • 1
  1. 1.National Heart HospitalLondon W.1.UK

Personalised recommendations